UK

Polio Could Return To Europe As A Result Of Syrian Crisis, Warn Academics

08/11/2013 07:07 GMT | Updated 08/11/2013 07:07 GMT
PA
A nurse handles a syringe at a medical centre in Ashford, Kent, similar to those which will be used for a new combined jab for babies. The vaccination will protect children against Diptheria, Tetanus, Whooping Cough, Hib and Polio and will be administered to babies over two-months-old later this year. Plans for a shake-up of the vaccine regime for babies are being formally unveiled by senior health officials today. But health campaigners and politicians have warned the Government that it risks a repeat of the MMR controversy unless more reassurances are given about the safety of a new five-in-one immunisation jab. The Government's plans for a combined vaccination emerged over the weekend, when the Department of Health also confirmed that mercury is to be removed from the whooping cough vaccine. 10/09/04: There is no evidence to support a link between the controversial MMR jab and the development of autism in children, researchers said Friday September 10, 2004. Concern about a reported link between the triple vaccine and the disorder has led to a drop in the number of parents getting their children vaccinated against measles, mumps and rubella in the UK. *07/12/04: Immunisation against infectious disease has saved more lives than any other public health intervention in Irish history, apart from providing clean water, it is claimed. Minister of State Tim O'Malley urged parents to ensure their children were protected against infectious diseases.

Experts have raised the prospect of polio returning to Europe as a result of the Syrian crisis.

The continent was declared polio-free by the World Health Organisation (WHO) in 2002, but is now threatened by a new

outbreak of the disease reported in Syria, it is claimed.

But academics have warned that refugees fleeing the war-torn country could bring the disease back.

Two German infection experts writing in The Lancet medical journal highlight the fact that the polio vaccine currently used throughout Europe is not 100% effective.

In parts of Europe where vaccine coverage is low, including Bosnia and Herzegovina, Ukraine, and Austria,

immunisation levels may not be high enough to prevent sustained transmission of the polio virus, they stress.

The WHO has confirmed an outbreak of at least 10 cases of polio in Syria, where vaccination coverage has dramatically

decreased because of the civil war.

TOP STORIES OF THE DAY

With large numbers of people now fleeing Syria and seeking refuge in neighbouring countries and Europe, polio could reappear in areas that have been free of the disease for decades.

"Vaccinating only Syrian refugees - as has been recommended by the European Centre for Disease Prevention and Control - must be judged as insufficient; more comprehensive measures should be taken into consideration," said Professor Martin Eichner, from the University of Tubingen, and Dr Stefan Brockmann, from the Department of Infection Control in Reutlingen.

The polio vaccine used in most European countries today is the inactivated polio vaccine (IPC), which is injected. It usually forms part of a combined diphtheria, tetanus, whooping cough and polio jab.

While good at preventing paralysis, IPC provides only partial protection from infection, Prof Eichner and Dr Brockmann point out.

Once children were routinely vaccinated with an oral polio vaccine (OPV), taken in the form of mouth drops, which uses a live virus and is more effective. But this was discontinued in the UK and many other countries because in rare cases it can trigger paralysis.

Since only one in 200 polio infections cause symptoms, the virus could be circulating for nearly a year before a single case of paralysis occurs, according to the experts. By this time, hundreds of individuals may be carrying the virus.

Prof Eichner and Dr Brockmann wrote: "Hundreds of thousands of people are fleeing Syria and seek refuge in neighbouring countries and Europe. Because only one in 200 unvaccinated individuals infection with WPV1 (wild-type polio virus 1) will develop acute flaccid paralysis, infected individuals can spread the virus unrecognised.

"Oral polio vaccination provides high protection against acquisition and spreading of the infection, but this vaccine was discontinued in Europe because of rare cases of vaccination-related acute flaccid paralysis.

"Only some of the European Union member states still allow its use and none has a stockpile of oral polio vaccines. Routine screening of sewage for polio virus has not been done in most European countries, but this intensified s

urveillance measure should be considered for settlements with large numbers of Syrian refugees."

PREVIOUSLY ON HUFFPOST: